AMERICAN CENTURY COMPANIES INC – Neurocrine Biosciences, Inc. Transaction History
AMERICAN CENTURY COMPANIES INC portfolio value:
$110.83M
portfolio value
AMERICAN CENTURY COMPANIES INC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.23% | -69.32K shares | 2.35M | $106.21 | 1.04M |
| Q2 2022 | share | Increase | +39.83% | 316.98K shares | 33.86M | $97.48 | 1.11M |
| Q1 2022 | share | Increase | +534.48% | 670.41K shares | 63.92M | $93.75 | 795.84K |
| Q4 2021 | share | Increase | +5.12% | 6.11K shares | -761K | $84.63 | 125.43K |
| Q3 2021 | share | Decrease | -8.56% | -11.17K shares | -1.25M | $95.91 | 119.31K |
| Q2 2021 | share | Decrease | -10.45% | -15.22K shares | -1.47M | $97.32 | 130.48K |
| Q1 2021 | share | Decrease | -0.21% | -308 shares | 174K | $97.25 | 145.70K |
| Q4 2020 | share | Decrease | -27.93% | -56.57K shares | -5.48M | $95.85 | 146.01K |
| Q3 2020 | share | Decrease | -6.50% | -14.09K shares | -6.95M | $96.16 | 202.59K |
| Q2 2020 | share | Increase | +36.70% | 58.17K shares | 12.71M | $122 | 216.68K |
| Q1 2020 | share | Decrease | -31.97% | -74.50K shares | -11.32M | $86.55 | 158.51K |
| Q4 2019 | share | Increase | +3.03% | 6.85K shares | 4.66M | $107.49 | 233.02K |
| Q3 2019 | share | Increase | +0.15% | 336 shares | 1.31M | $90.11 | 226.16K |
| Q2 2019 | share | Increase | +21.65% | 40.18K shares | 2.71M | $84.43 | 225.83K |
| Q1 2019 | share | Increase | +25.32% | 37.50K shares | 5.77M | $88.1 | 185.64K |
| Q4 2018 | share | Increase | 0.00% | 148.14K shares | 10.57M | $71.41 | 148.14K |
| Q3 2018 | share | Decrease | -100.00% | -566.89K shares | -55.69M | $122.95 | 0 |
| Q2 2018 | share | Increase | +14.02% | 69.70K shares | 14.46M | $98.24 | 566.89K |
| Q1 2018 | share | Increase | +1.33% | 6.54K shares | 3.16M | $82.93 | 497.19K |
| Q4 2017 | share | Increase | +1257.33% | 454.5K shares | 35.85M | $77.59 | 490.64K |
| Q3 2017 | share | Increase | +7.25% | 2.44K shares | 665K | $61.28 | 36.14K |
| Q2 2017 | share | Increase | +2.70% | 886 shares | 129K | $46 | 33.70K |
| Q1 2017 | share | Decrease | -89.42% | -277.41K shares | -10.58M | $43.3 | 32.81K |
| Q4 2016 | share | Decrease | -64.77% | -570.27K shares | -32.58M | $38.7 | 310.23K |
| Q3 2016 | share | Increase | +7.18% | 58.98K shares | 7.25M | $50.64 | 880.50K |
| Q2 2016 | share | Increase | +890.64% | 738.59K shares | 34.05M | $45.45 | 821.52K |
| Q1 2016 | share | Decrease | -2.90% | -2.47K shares | -1.55M | $39.55 | 82.92K |